Vaxcyte
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vaxcyte and other ETFs, options, and stocks.About PCVX
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology.
CEOGrant E. Pickering
CEOGrant E. Pickering
Employees414
Employees414
HeadquartersSan Carlos, California
HeadquartersSan Carlos, California
Founded2013
Founded2013
Employees414
Employees414
PCVX Key Statistics
Market cap6.10B
Market cap6.10B
Price-Earnings ratio-9.47
Price-Earnings ratio-9.47
Dividend yield—
Dividend yield—
Average volume997.66K
Average volume997.66K
High today$48.93
High today$48.93
Low today$46.54
Low today$46.54
Open price$48.04
Open price$48.04
Volume965.77K
Volume965.77K
52 Week high$93.77
52 Week high$93.77
52 Week low$27.66
52 Week low$27.66
Stock Snapshot
With a market cap of 6.1B, Vaxcyte(PCVX) trades at $46.60. The stock has a price-to-earnings ratio of -9.47.
During the trading session on 2026-01-17, Vaxcyte(PCVX) shares reached a daily high of $48.93 and a low of $46.54. At a current price of $46.60, the stock is +0.1% higher than the low and still -4.8% under the high.
Trading activity shows a volume of 965.77K, compared to an average daily volume of 997.66K.
The stock's 52-week range extends from a low of $27.66 to a high of $93.77.
The stock's 52-week range extends from a low of $27.66 to a high of $93.77.
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own PCVX. This list is generated using Robinhood data, and it’s not a recommendation.